Antimicrobial susceptibility patterns of enterococci in intensive care units in Sweden evaluated by different MIC breakpoint systems

Journal of Antimicrobial Chemotherapy

Volumn 48, Issue 1, 2001, Pages 53-62

  Hällgren, Anita ^a   Abednazari, Hossein ^a   Ekdahl, Christer ^a   Hanberger, Håkan ^a   Nilsson, Maud ^a   Samuelsson, Annika ^a   Svensson, Erik ^a   Nilsson, Lennart E ^a   Claesson, Berndt ^b   Kärnell, Anders ^b   Kjellberg, Erik ^b   Larsson, Peter ^b   Rylander, Margareta ^b   Sörén, Lars ^b  

^a Fac Hlth Sci   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CIPROFLOXACIN; CLINAFLOXACIN; DALFOPRISTIN PLUS QUINUPRISTIN; EVERNIMICIN; GENTAMICIN; IMIPENEM; LINEZOLID; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOMYCIN; TEICOPLANIN; TROVAFLOXACIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; EVALUATION; HOSPITAL ADMISSION; INTENSIVE CARE UNIT; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; ORGANIZATION; SWEDEN; TIME;

EID: 0034921780     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/48.1.53     Document Type: Article

References (49)

1. Surveillance of antibiotic resistance in ICUs in southeastern Sweden
2. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study
3. Outbreak of a multiresistant Klebsiella pneumoniae strain in an intensive care unit: Antibiotic use as risk factor for colonisation and infection
4. The life and times of the Enterococcus
5. Species identification and antibiotic susceptibility testing of enterococci isolated from hospitalized patients
6. Multiple-drug resistant enterococci: The nature of the problem and an agenda for the future
7. Epidemiologic evaluation of antimicrobial resistance in community-acquired enterococci
8. Increasing resistance to beta-lactam antibiotics among clinical isolates of Enterococcus faecium: A 22-year review at one institution
9. Incidence and detection of multi-drug-resistant enterococci in Dublin hospitals
10. Vancomycin-resistant enterococci at a large university hospital in Denmark
11. Spread of vancomycin-resistant enterococci: Differences between the United States and Europe
12. Intrahospital spread of vancomycin-resistant Enterococcus faecium in Sweden
13. Near absence of vancomycin-resistant enterococci but high carriage rates of quinolone-resistant ampicillin-resistant enterococci among hospitalized patients and nonhospitalized individuals in Sweden
14. New species-related MIC breakpoints for early detection of development of resistance among Gram-negative bacteria in Swedish intensive care units
15. Methods for Dilution Antimicrobial Tests for Bacteria that Grow Aerobically: Approved Standard M7-A5
16. Evaluation of in vitro activity of quinupristin/dalfopristin and comparator antimicrobial agents against worldwide clinical trial and other laboratory isolates
17. In vitro activity of linezolid against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae
18. Comparative in-vitro activity of SCH 27899, a novel everninomicin, and vancomycin
19. In vitro activities of SCH27899 alone and in combination with 17 other antimicrobial agents
20. The in-vitro activity of trovafloxacin, a new fluoroquinolone, against Gram-positive bacteria
21. The comparative in vitro activity of clinafloxacin and other antimicrobials against vancomycin-susceptible and vancomycin-resistant enterococci
22. Enterococcus
23. Acidification of methyl-β-D-glucopyranoside: A useful test to differentiate Enterococcus casseliflavus and Enterococcus gallinarum from Enterococcus faecium species group and from Enterococcus faecalis
24. Detection of vancomycin resistance genes combined with typing of Enterococci by means of multiplex PCR amplification and multiple primer DNA sequencing
25. Division of the genus Enterococcus into species groups using PCR-based molecular typing methods
26. Reliability of the Etest for detection of ampicillin, vancomycin and high-level aminoglycoside resistance in Enterococcus spp
27. Activity of linezolid against multi-resistant Gram-positive bacteria from diverse hospitals in the United Kingdom
28. Surveillance of antibiotic resistance in European ICUs
29. Survey of enterococcal susceptibility patterns in Belgium
30. Antimicrobial susceptibility patterns of enterococci causing infections in Europe
31. Intrinsically vancomycin-resistant gram-positive organisms: Clinical relevance and implications for infection control
32. Comparison of eight methods to detect vancomycin resistance in enterococci
33. Accuracy of the E test for determining antimicrobial susceptibilities of staphylococci, enterococci, Campylobacter jejuni and gram-negative bacteria resistant to antimicrobial agents
34. Intrinsic penicillin resistance in enterococci
35. Antibiotic resistance among enterococci isolated from clinical specimens between 1953 and 1954
36. Diversity among multidrug-resistant enterococci
37. Overproduction of a low-affinity penicillin-binding protein and high-level ampicillin resistance in Enterococcus faecium
38. Comparative study of bacteremias caused by Enterococcus spp. with and without high-level resistance to gentamicin
39. Increasing resistance of enterococci to ciprofloxacin
40. Usage of antibacterial and antiparasitic drugs in animals in Sweden between 1988 and 1993
41. Quinupristin/dalfopristin: Spectrum of activity, pharmacokinetics, and initial clinical experience
42. Effect of quinupristin/dalfopristin on the outcome of vancomycin-resistant Enterococcus faecium bacteraemia: Comparison with a control cohort
43. Treatment of vancomycin-resistant Enterococcus faecium infections with an investigational streptogramin antibiotic (quinupristin/dalfopristin): A report of fifteen cases
44. Emergence of increased resistance to quinupristin/dalfopristin during therapy for Enterococcus faecium bacteremia
45. In vitro susceptibilities of enterococcal blood culture isolates from the Hamburg area to ten antibiotics
46. Antimicrobial activity of Quinupristin-Dalfopristin (RP 59500, Synercid®) tested against over 28 000 recent clinical isolates from 200 medical centers in the United States and Canada
47. In vitro Gram-positive antimicrobial activity of evernimicin (SCH 27899), a novel oligosaccharide, compared with other antimicrobials: A multicentre study